Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Sabatier

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Infectious Disorders Drug Targets|May 24, 2014
Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infectionsHanen Ghodhbane, Sabrine Elaidi, Jean-Marc Sabatier, et al.
Molecules (Basel, Switzerland)|April 9, 2020
Novel Mutant Phospholipase D from <i>Hemiscorpius lepturus</i> Acts as A Highly Immunogen in BALB/c Mice Against the Lethality of Scorpion VenomAbouzar Soleimani Moez, Reza H Sajedi, Kamran Pooshang Bagheri, et al.
Biochemical and Biophysical Research Communications|September 14, 2016
Mechanism of action and in vitro activity of short hybrid antimicrobial peptide PV3 against Pseudomonas aeruginosaHamed Memariani, Delavar Shahbazzadeh, Jean-Marc Sabatier, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Cell penetration properties of a highly efficient mini maurocalcine PeptideCéline Tisseyre, Eloi Bahembera, Lucie Dardevet, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Inhibitors of ATP Synthase as New Antibacterial CandidatesRawan Mackieh, Nadia Al-Bakkar, Milena Kfoury, et al.
Molecules (Basel, Switzerland)|August 22, 2019
Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic InterestsRim Wehbe, Jacinthe Frangieh, Mohamad Rima, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 18, 2019
Development of a human scFv antibody targeting the lethal Iranian cobra (Naja oxiana) snake venomFatemeh Kazemi-Lomedasht, Montarop Yamabhai, Jean-Marc Sabatier, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Snake Venom Components: Tools and Cures to Target Cardiovascular DiseasesJacinthe Frangieh, Mohamad Rima, Ziad Fajloun, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Beehive Products as Antibacterial Agents: A ReviewRita Abou Nader, Rawan Mackieh, Rim Wehbe, et al.
Viruses|March 28, 2024
Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive ReviewHadi Al-Jamal, Sara Idriss, Rabih Roufayel, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Infectious Disorders Drug Targets|May 24, 2014
Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infectionsHanen Ghodhbane, Sabrine Elaidi, Jean-Marc Sabatier, et al.
Molecules (Basel, Switzerland)|April 9, 2020
Novel Mutant Phospholipase D from <i>Hemiscorpius lepturus</i> Acts as A Highly Immunogen in BALB/c Mice Against the Lethality of Scorpion VenomAbouzar Soleimani Moez, Reza H Sajedi, Kamran Pooshang Bagheri, et al.
Biochemical and Biophysical Research Communications|September 14, 2016
Mechanism of action and in vitro activity of short hybrid antimicrobial peptide PV3 against Pseudomonas aeruginosaHamed Memariani, Delavar Shahbazzadeh, Jean-Marc Sabatier, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
Cell penetration properties of a highly efficient mini maurocalcine PeptideCéline Tisseyre, Eloi Bahembera, Lucie Dardevet, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Inhibitors of ATP Synthase as New Antibacterial CandidatesRawan Mackieh, Nadia Al-Bakkar, Milena Kfoury, et al.
Molecules (Basel, Switzerland)|August 22, 2019
Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic InterestsRim Wehbe, Jacinthe Frangieh, Mohamad Rima, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 18, 2019
Development of a human scFv antibody targeting the lethal Iranian cobra (Naja oxiana) snake venomFatemeh Kazemi-Lomedasht, Montarop Yamabhai, Jean-Marc Sabatier, et al.
Molecules (Basel, Switzerland)|April 30, 2021
Snake Venom Components: Tools and Cures to Target Cardiovascular DiseasesJacinthe Frangieh, Mohamad Rima, Ziad Fajloun, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Beehive Products as Antibacterial Agents: A ReviewRita Abou Nader, Rawan Mackieh, Rim Wehbe, et al.
Viruses|March 28, 2024
Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive ReviewHadi Al-Jamal, Sara Idriss, Rabih Roufayel, et al.
Pageof 15